On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment

Experimental Cell Research

Volumn 319, Issue 12, 2013, Pages 1828-1838

  Eibinger, Gerald ^a   Fauler, Günter ^a   Bernhart, Eva ^a   Frank, Sasa ^a   Hammer, Astrid ^a   Wintersperger, Andrea ^a   Eder, Hans ^a   Heinemann, Akos ^a   Mischel, Paul S ^b   Malle, Ernst ^a   Sattler, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (United States)

Author keywords

EBI2; Glioblastoma; IL1 ; Migration; TNF

Indexed keywords

25 HYDROXYCHOLESTEROL; CHOLESTEROL 25 HYDROXYLASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 183; INTERLEUKIN 1BETA; LIPID; OXYGENASE; OXYSTEROL; PERTUSSIS TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL STRUCTURE; CHOLESTEROL SYNTHESIS; CULTURE MEDIUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LEUKEMIA CELL LINE; MACROPHAGE; MONOCYTE; MONOCYTIC LEUKEMIA; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA INTERFERENCE; RNA TRANSLATION; TRANSCRIPTION REGULATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL LINE; TUMOR IMMUNITY; UPREGULATION;

EID: 84879606336     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.03.025     Document Type: Article

References (59)

1. Jusakul A., Yongvanit P., Loilome W., Namwat N., Kuver R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis. 2011, 10:44.
2. Bjorkhem I., Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 2004, 24:806-815.
3. Wang Y., Muneton S., Sjovall J., Jovanovic J.N., Griffiths W.J. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J. Proteome Res. 2008, 7:1606-1614.
4. Park K., Scott A.L. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J. Leukoc. Biol. 2010, 88:1081-1087.
5. Diczfalusy U., Olofsson K.E., Carlsson A.M., Gong M., Golenbock D.T., Rooyackers O., Flaring U., Bjorkbacka H. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res. 2009, 50:2258-2264.
6. Villablanca E.J., Raccosta L., Zhou D., Fontana R., Maggioni D., Negro A., Sanvito F., Ponzoni M., Valentinis B., Bregni M., Prinetti A., Steffensen K.R., Sonnino S., Gustafsson J.A., Doglioni C., Bordignon C., Traversari C., Russo V. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 2010, 16:98-105.
7. Traversari C., Russo V. Control of the immune system by oxysterols and cancer development. Curr. Opin. Pharmacol. 2012, 12:729-735.
8. Repa J.J., Li H., Frank-Cannon T.C., Valasek M.A., Turley S.D., Tansey M.G., Dietschy J.M. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci. 2007, 27:14470-14480.
9. Waltl S., Patankar J.V., Fauler G., Nusshold C., Ullen A., Eibinger G., Wintersperger A., Kratky D., Malle E., Sattler W. 25-Hydroxycholesterol regulates cholesterol homeostasis in the murine CATH.a neuronal cell line. Neurosci. Lett. 2013, 539:16-21.
10. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Nat. Acad Sci. U.S.A. 2001, 98:507-512.
11. Tam S.P., Ramharack R. The effect of 25-hydroxycholesterol on the regulation of apolipoprotein E mRNA levels and secretion in the human hepatoma HepG2. Atherosclerosis 1992, 95:137-146.
12. Brahimi F., Bertrand P., Starck M., Galteau M.M., Siest G. Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2. Cell Biochem. Funct. 2001, 19:51-58.
13. Makoukji J., Shackleford G., Meffre D., Grenier J., Liere P., Lobaccaro J.M., Schumacher M., Massaad C. Interplay between LXR and Wnt/beta-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols. J. Neurosci. 2011, 31:9620-9629.
14. Guo D., Reinitz F., Youssef M., Hong C., Nathanson D., Akhavan D., Kuga D., Amzajerdi A.N., Soto H., Zhu S., Babic I., Tanaka K., Dang J., Iwanami A., Gini B., Dejesus J., Lisiero D.D., Huang T.T., Prins R.M., Wen P.Y., Robins H.I., Prados M.D., Deangelis L.M., Mellinghoff I.K., Mehta M.P., James C.D., Chakravarti A., Cloughesy T.F., Tontonoz P., Mischel P.S. An LXR agonist promotes GBM cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 2011, 1:442-456.
15. Chuu C.P., Lin H.P. Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer Res. 2010, 30:3643-3648.
16. Fukuchi J., Kokontis J.M., Hiipakka R.A., Chuu C.P., Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res. 2004, 64:7686-7689.
17. Chuu C.P., Hiipakka R.A., Kokontis J.M., Fukuchi J., Chen R.Y., Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res. 2006, 66:6482-6486.
18. Chuu C.P. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Med. Hypotheses 2011, 76:697-699.
19. Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
20. Nachtergaele S., Mydock L.K., Krishnan K., Rammohan J., Schlesinger P.H., Covey D.F., Rohatgi R. Oxysterols are allosteric activators of the oncoprotein Smoothened. Nat. Chem. Biol. 2012, 8:211-220.
21. Corcoran R.B., Scott M.P. Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc. Nat. Acad. Sci. U.S.A. 2006, 103:8408-8413.
22. Xu L., Shen S., Ma Y., Kim J.K., Rodriguez-Agudo D., Heuman D.M., Hylemon P.B., Pandak W.M., Ren S. 25-Hydroxycholesterol-3-sulfate (25HC3S) attenuates inflammatory response via PPARgamma signaling in human THP-1 macrophages. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E788-799.
23. Russo V. Metabolism, LXR/LXR ligands, and tumor immune escape. J. Leukoc. Biol. 2011, 90:673-679.
24. Stupp R., Hegi M.E., van den Bent M.J., Mason W.P., Weller M., Mirimanoff R.O., Cairncross J.G. Changing paradigms-an update on the multidisciplinary management of malignant glioma. Oncologist 2006, 11:165-180.
25. Guo D., Hildebrandt I.J., Prins R.M., Soto H., Mazzotta M.M., Dang J., Czernin J., Shyy J.Y., Watson A.D., Phelps M., Radu C.G., Cloughesy T.F., Mischel P.S. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:12932-12937.
26. Bauman D.R., Bitmansour A.D., McDonald J.G., Thompson B.M., Liang G., Russell D.W. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:16764-16769.
27. Liu Y., Hulten L.M., Wiklund O. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler. Thromb. Vasc. Biol. 1997, 17:317-323.
28. Rydberg E.K., Salomonsson L., Hulten L.M., Noren K., Bondjers G., Wiklund O., Bjornheden T., Ohlsson B.G. Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis 2003, 170:245-252.
29. Hannedouche S., Zhang J., Yi T., Shen W., Nguyen D., Pereira J.P., Guerini D., Baumgarten B.U., Roggo S., Wen B., Knochenmuss R., Noel S., Gessier F., Kelly L.M., Vanek M., Laurent S., Preuss I., Miault C., Christen I., Karuna R., Li W., Koo D.I., Suply T., Schmedt C., Peters E.C., Falchetto R., Katopodis A., Spanka C., Roy M.O., Detheux M., Chen Y.A., Schultz P.G., Cho C.Y., Seuwen K., Cyster J.G., Sailer A.W. Oxysterols direct immune cell migration via EBI2. Nature 2011, 475:524-527.
30. Liu C., Yang X.V., Wu J., Kuei C., Mani N.S., Zhang L., Yu J., Sutton S.W., Qin N., Banie H., Karlsson L., Sun S., Lovenberg T.W. Oxysterols direct B-cell migration through EBI2. Nature 2011, 475:519-523.
31. Yeung Y.T., Bryce N.S., Adams S., Braidy N., Konayagi M., McDonald K.L., Teo C., Guillemin G.J., Grewal T., Munoz L. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J. Neurooncol. 2012, 109:35-44.
32. Sharma V., Dixit D., Koul N., Mehta V.S., Sen E. Ras regulates interleukin-1beta-induced HIF-1alpha transcriptional activity in glioblastoma. J. Mol. Med. (Berl.) 2011, 89:123-136.
33. Zhu V.F., Yang J., Lebrun D.G., Li M. Understanding the role of cytokines in glioblastoma multiforme pathogenesis. Cancer Lett. 2012, 316:139-150.
34. Ye X.Z., Xu S.L., Xin Y.H., Yu S.C., Ping Y.F., Chen L., Xiao H.L., Wang B., Yi L., Wang Q.L., Jiang X.F., Yang L., Zhang P., Qian C., Cui Y.H., Zhang X., Bian X.W. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 2012, 189:444-453.
35. Wang Y., Zhu S., Cloughesy T.F., Liau L.M., Mischel P.S. p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition. Oncogene 2004, 23:1283-1290.
36. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
37. Folch J., Lees M., Stanley G.H.Sloane A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
38. Fan H., Hall P., Santos L.L., Gregory J.L., Fingerle-Rowson G., Bucala R., Morand E.F., Hickey M.J. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. J. Immunol. 2011, 186:4915-4924.
39. Ulcar R., Peskar B.A., Schuligoi R., Heinemann A., Kessler H.H., Santner B.I., Amann R. Cyclooxygenase inhibition in human monocytes increases endotoxin-induced TNF alpha without affecting cyclooxygenase-2 expression. Eur. J. Pharmacol. 2004, 501:9-17.
40. Baay M., Brouwer A., Pauwels P., Peeters M., Lardon F. Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin. Dev. Immunol. 2011, 565187.
41. Rosenkilde M.M., Benned-Jensen T., Andersen H., Holst P.J., Kledal T.N., Luttichau H.R., Larsen J.K., Christensen J.P., Schwartz T.W. Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J. Biol. Chem. 2006, 281:13199-13208.
42. Guo D., Dunbar J.D., Yang C.H., Pfeffer L.M., Donner D.B. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J. Immunol. 1998, 160:2742-2750.
43. Lee S.H., Nishino M., Mazumdar T., Garcia G.E., Galfione M., Lee F.L., Lee C.L., Liang A., Kim J., Feng L., Eissa N.T., Lin S.H., Yu-Lee L.Y. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway. Cancer Res. 2005, 65:7984-7992.
44. Tsukada J., Waterman W.R., Koyama Y., Webb A.C., Auron P.E. A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene. Mol. Cell Biol. 1996, 16:2183-2194.
45. Lange Y., Ye J., Strebel F. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J. Lipid Res. 1995, 36:1092-1097.
46. Theunissen J.J., Jackson R.L., Kempen H.J., Demel R.A. Membrane properties of oxysterols. Interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biophys. Acta 1986, 860:66-74.
47. Babiker A., Diczfalusy U. Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Biophys. Acta 1998, 1392:333-339.
48. Van Brocklyn J., Letterle C., Snyder P., Prior T. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. Cancer Lett. 2002, 181:195-204.
49. Malchinkhuu E., Sato K., Muraki T., Ishikawa K., Kuwabara A., Okajima F. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function. Biochem. J. 2003, 370:817-827.
50. Zhang L., Shih A.Y., Yang X.V., Kuei C., Wu J., Deng X., Mani N.S., Mirzadegan T., Sun S., Lovenberg T.W., Liu C. Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site. Mol. Pharmacol. 2012, 82:1094-1103.
51. Yi T., Wang X., Kelly L.M., An J., Xu Y., Sailer A.W., Gustafsson J.A., Russell D.W., Cyster J.G. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. Immunity 2012, 37:535-548.
52. Benned-Jensen T., Norn C., Laurent S., Madsen C.M., Larsen H.M., Arfelt K.N., Wolf R.M., Frimurer T., Sailer A.W., Rosenkilde M.M. Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183). J. Biol. Chem. 2012, 287:35470-35483.
53. Bursill C.A., Castro M.L., Beattie D.T., Nakhla S., van der Vorst E., Heather A.K., Barter P.J., Rye K.A. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1773-1778.
54. Silva J., Beckedorf A., Bieberich E. Osteoblast-derived oxysterol is a migration-inducing factor for human breast cancer cells. J. Biol. Chem. 2003, 278:25376-25385.
55. Ivaska J., Pallari H.M., Nevo J., Eriksson J.E. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 2007, 313:2050-2062.
56. Nieminen M., Henttinen T., Merinen M., Marttila-Ichihara F., Eriksson J.E., Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell Biol. 2006, 8:156-162.
57. Schmid M.C., Varner J.A. Myeloid cells in tumor inflammation. Vasc. Cell 2012, 4:14.
58. Parney I.F., Waldron J.S., Parsa A.T. Flow cytometry and in vitro analysis of human glioma-associated macrophages. J. Neurosurg. 2009, 110:572-582.
59. Charles N.A., Holland E.C., Gilbertson R., Glass R., Kettenmann H. The brain tumor microenvironment. Glia 2011, 59:1169-1180.